11 03, 2018

Lurasidone (Latuda) Gains FDA Approval for Bipolar Depression in Kids

By | 2018-03-11T08:25:45+00:00 March 11th, 2018|Brainscience Blogs|0 Comments

The US Food and Drug Administration (FDA) has approved a supplemental new drug application for lurasidone (Latuda) for the treatment of major depressive episodes associated with bipolar I disorder (bipolar depression) in children and adolescents aged 10 to 17 years. Lurasidone, a serotonin dopamine antagonist, is already approved in the [...]

5 03, 2018

Viewpoint: Treating Bipolar Disorder Like Cancer

By | 2018-03-05T17:53:21+00:00 March 5th, 2018|Brainscience Blogs|0 Comments

In a fascinating note in today's Journal of the American Medical Association (JAMA), Robert M. Post of the George Washington University School of Medicine attributes stigma as one of the main factors contributing to inadequate recognition and treatment of recurrent mood disorders, including unipolar depression and bipolar disorder. "This Viewpoint describes an [...]

1 03, 2018

Top 5 Articles of February 2018

By | 2018-03-01T08:40:38+00:00 March 1st, 2018|Brainscience Blogs|0 Comments

Top 5 Articles of February 2018 Updated for 2018 Dosing and Monitoring: Child and Adolescent Psychotropic Criteria For Children And Adolescents Psychotropic Drugs: Side Effects And Teratogenic Risks Recommended Clinical Monitoring Of Children And Adolescents For Psychotropic Drugs Internet Resources READ MORE A Pilot Evaluating Clinical Pharmacy Services in an [...]

12 02, 2018

Married to an Alcoholic? You, Too, Are at Risk

By | 2018-02-12T09:38:04+00:00 February 12th, 2018|Brainscience Blogs|0 Comments

The increase in risk for alcohol use disorder (AUD) in a married individual following a diagnosis of alcoholism in the other spouse is "large and rapid," according to researchers writing recently in JAMA. The causes of this association remain unclear. Population-wide Swedish registries were used to identify individuals born in [...]

29 01, 2018

Is Methamphetamine-Induced Psychosis Reversible?

By | 2018-01-29T11:21:52+00:00 January 29th, 2018|Brainscience Blogs, Brief Bulletins from the Field|0 Comments

According to an evidence-based review in the journal Current Psychiatry, the answer is a qualified "Maybe." Chronic methamphetamine use can induce pathological brain changes in the brain. Users can develop thought, mood, and behavioral disorders, including psychosis. Such effects may persist even after extended abstinence. Because cognitive deficits can affect [...]

25 01, 2018

Continuing Medical Education: Ascent to the Summit of the Pyramid

By | 2018-01-25T16:02:13+00:00 January 25th, 2018|Brainscience Blogs, Brief Bulletins from the Field|0 Comments

By Robin Stevenson, and Donald E. Moore Jr. Medical education is a continuum of 3 parts; undergraduate medical school education, postgraduate training, and continuing medical education (CME). CME differs from the other 2 educational components in that it has generally not been based on an explicit curriculum. Recently, CME has increasingly focused on addressing professional [...]

25 01, 2018

Eli Lilly’s EXPEDITION3 data is a costly lesson in rethinking Alzheimer’s

By | 2018-01-25T14:45:07+00:00 January 25th, 2018|Brainscience Blogs, Brief Bulletins from the Field|0 Comments

Eli Lilly had hoped that EXPEDITION3 would prove to the world that amyloid beta was the cause of Alzheimer’s and that solanezumab could bend the curve of cognitive decline back to patients’ favor — or at least for patients with an early-stage, mild form of the disease. Instead, the landmark failure [...]

25 01, 2018

Medical marijuana: Do the benefits outweigh the risks?

By | 2018-01-25T14:27:56+00:00 January 25th, 2018|Brainscience Blogs, Brief Bulletins from the Field|0 Comments

By Sheila Gupta, Tiffany Phalen, and Sanjay Gupta There is a need for additional treatment options to improve symptoms, enhance the quality of life (QOL), and reduce suffering among patients who have chronic medical illness. Medical marijuana (MM) has the potential to help patients who have certain medical conditions in states where it [...]

25 01, 2018

Depression and Anxiety Seen in Those Concerned About Climate Change

By | 2018-01-25T14:09:52+00:00 January 25th, 2018|Brainscience Blogs, Brief Bulletins from the Field|0 Comments

NEW YORK (Thomson Reuters Foundation) - Depression and anxiety afflict Americans who are concerned with the fate of the environment, according to a study of the mental health effects of climate change. Most hard-hit are women and people with low incomes who worry about the planet's long-term health, said the [...]